TRANSPARENCY COUNCIL MEETING NO. 40/2023 OCTOBER 9, 2023
1. Imfinzi (durvalumabum) Indication: under the drug program "Treatment of patients with biliary tract cancer (ICD-10: C22.1, C23, C24.0, C24.1, C24.8, C24.9) Decision problem: preparation of a position paper on the evaluation of the drug
2. Rinvoq (upadacitinibum) CONDITIONAL Indication: under drug program B.32. "Treatment of patients with Crohn's disease (ICD-10: K50)". Decision-making problem: preparation of a position paper on the evaluation of the drug
3. "Health policy program for detection of hearing disorders in children attending schools and institutions from the Municipality of Krakow" Decision-making problem: preparation of an opinion on the draft health policy program of local government units
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
